In elucidating the mechanism of RCC development, our findings suggest that high dietary intake of PUFAs induces changes in plasma PC and LysoPC levels, and the downregulation of CPT1, leading to decreased acylcarnitine levels, which likely impacts lipid synthesis and contributes to RCC onset. This evidence concerns the gene CPT2 and renal cell carcinoma.